Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA approves afamelanotide for treatment of rare condition with light-induced pain
- Author:
- Christopher Palmer
This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Vaccine_syringe_web.jpg)
Interventions significantly improve NICU immunization rates
- Author:
- Christopher Palmer
The researchers implemented five interventions and went from fully immunizing slightly more than half to almost every infant in the neonatal ICU...
News
Secukinumab continues promising axial spondyloarthritis results in PREVENT
- Author:
- Christopher Palmer
Results from 52 weeks showed significantly greater improvement among patients taking secukinumab for nonradiographic disease, compared with...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA approves benralizumab autoinjector for eosinophilic asthma
- Author:
- Christopher Palmer
Benralizumab is already approved as add-on maintenance for this form of asthma, but not for other eosinophilic conditions or for acute...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA expands Dysport’s upper-limb spasticity indication to children
- Author:
- Christopher Palmer
AbobotulinumtoxinA (Dysport) is now approved for upper-limb spasticity in both children 2 years and older (excluding those with cerebral palsy)...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
Daratumumab approved in combo with VTd for transplant-eligible multiple myeloma
- Author:
- Christopher Palmer
This marks the drug’s second approved indication this year and its seventh overall.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_icon3_web.jpg)
FDA: Sandoz recalls ranitidine capsules with NDMA
- Author:
- Christopher Palmer
The affected lots were recalled because NDMA, a nitrosamine impurity and probable carcinogen, was detected at levels above those set by the FDA....
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/mother_child_clap_web.jpg)
Sensitive, responsive parenting improves child language skills
- Author:
- Christopher Palmer
The association was stronger among families with lower socioeconomic status than among those with middle or high socioeconomic status.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Sleepless_insomnia_woman_web.jpg)
Adult insomnia associated with childhood behavioral problems
- Author:
- Christopher Palmer
The association was particularly strong with externalizing behavioral problems.
News
Gastrostomy tube placement associated with higher pneumonia recurrence in children with neurologic impairment
- Author:
- Christopher Palmer
Dental care was the only prevention strategy of eight examined that was linked to decreased recurrence.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_icon3_web.jpg)
FDA grants sirolimus-eluting balloon breakthrough device designation for PAD
- Author:
- Christopher Palmer
The sirolimus-eluting balloon delivers the drug for below-the-knee peripheral artery disease without the need...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA approves mepolizumab for severe eosinophilic asthma in younger kids
- Author:
- Christopher Palmer
The biologic has been approved for patients aged 6 years and older in the European Union since August 2018.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA approves tenapanor for IBS with constipation
- Author:
- Christopher Palmer
Improvements in number of complete spontaneous bowel movements and abdominal pain were seen as early as week 1 of the phase 3 trials.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA approves nintedanib for scleroderma interstitial lung disease
- Author:
- Christopher Palmer
Interstitial lung disease affects half of scleroderma patients in the United States, and until now there was no treatment.
News
Higher BMD linked to family history of diabetes in postmenopausal women
- Author:
- Christopher Palmer
The connection may be related to insulin resistance.